HIV/AIDS and STBBI Research Initiative
The CIHR HIV/AIDS and STBBI (Sexually Transmitted and Blood-Borne Infections) Research Initiative is led by the CIHR Institute of Infection and Immunity (III) under the leadership of Dr. Charu Kaushic.
The CIHR HIV/AIDS and STBBI Research Initiative (formerly the HIV/AIDS Research Initiative) is responsible for the management and oversight of the research components of the major Government of Canada initiative in HIV/AIDS namely the Federal Initiative to Address HIV/AIDS in Canada. As outlined in the Pan-Canadian STBBI Framework (Reducing the Health Impact of Sexually Transmitted and Blood-Borne Infections in Canada by 2030: A Pan-Canadian STBBI Framework for Action) and Canada's Action Plan on STBBI (Accelerating our response: Government of Canada five-year action plan on STBBI), Canada has adopted an integrated approach to HIV and STBBI across the full continuum of prevention, testing, initiation of care and treatment and ongoing care and support. Consequently, the mandate of the CIHR HIV/AIDS Research Initiative has been expanded to incorporate other STBBI, including but not limited to hepatitis B, hepatitis C, chlamydia, gonorrhea, syphilis, and human papilloma virus.
This initiative provides approximately $21M annually to support researchers and trainees through the four research funding streams of the CIHR HIV/AIDS and STBBI Research Initiative:
- Biomedical and clinical
- Health services and population health
- Community-Based Research
- CIHR Canadian HIV Trials Network
The CIHR HIV/AIDS and STBBI Research Initiative is guided by the CIHR HIV/AIDS and STBBI Research Advisory Committee (CHASRAC), which is comprised of members representing various areas of HIV/AIDS and STBBI research, government, and HIV/AIDS and/or STBBI community organizations.
- Date modified: